PAYX

Paychex is a textbook quality franchise: FY2025 revenue of $5.41B grew +5.4% while throwing off a 40.8% operating margin, 30.6% net margin and a 40.1% ROE — numbers that signal deeply recurring, mission-critical payroll/HCM revenue and pricing power. Operating cash flow was $1.90B against just $192M of capex, funding a $1.45B dividend (+10.1%). At $96.30 the stock trades at 21.0x EPS and 6.4x sales — full on an absolute basis but undemanding for a business of this quality, and below the premium multiple PAYX has historically commanded. This is the core of the bull case.

What keeps it a hold rather than a buy is the cost of the growth it just bought. Long-term debt exploded +469.5% to $4.55B (plus $400M current) and total liabilities jumped +88.9% — the balance-sheet footprint of the Paycor HCM acquisition that management foregrounds throughout the MD&A and forward-looking-statement disclosures. That leverage is the most plausible reason net income actually fell -2.0% and diluted EPS slipped -1.9% to $4.58 even as revenue and operating income rose: interest expense and integration drag are eating the top-line gains. Liabilities/equity now sits at 3.01x. The 10-K flags 'risks related to acquisitions and the integration of the businesses we acquire, including risks related to the integration of Paycor' as a top-line risk — execution here is the swing factor for the next two years.